Small Solutions for Big Problems in Drug Discovery and Delivery
Ijeoma Uchegbu, Professor of Pharmaceutical Nanoscience at UCL and Co-Founder and CSO of Nanomerics, gave one of this year's keynote presentations at ...
Tag: Chronic
Inequalities in green space linked to preventable deaths in urban areas
Study reveals that increasing green space in deprived urban neighborhoods could significantly reduce preventable deaths, highlighting the need for targeted ...
Retirement boosts social connection and reduces loneliness in the long term
European study reveals that retirees feel less lonely over time, with new social activities and personal connections helping reduce isolation—especially ...
Imbalances in NET homeostasis linked to portal vein thrombosis in CHB-related decompensated cirrhosis
Background and aims Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic ...
HMGB1 as a key mediator in liver disease pathogenesis
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates. Acute ...
Study links obstructive sleep apnea to increased dementia risk in women
A common yet underdiagnosed sleep disorder contributes to the development of dementia among adults -; particularly women, a Michigan Medicine ...
Researchers aim to transform treatment for sleep disorders in military personnel
Traditional solutions for sleep disorders, including medications and cognitive behavioral therapies, often provide insufficient relief for military personnel, a problem ...
New insights on the association between genes, gut microbiota, and mental health
Study links gut microbiome diversity and genetic variants in inflammatory bowel disease patients to increased risk of mental health disorders, ...
Investigating the relationship between COPD and liver disease in alpha-1 antitrypsin deficiency
Background and aims Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by the misfolding and accumulation of the mutant ...
Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B
Background and aims The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in patients with chronic hepatitis B (CHB) ...
